Weight Loss3 min read

Semaglutide 2.4mg in Australia: Patient Information

General patient information about semaglutide 2.4mg (the active ingredient in the brand Wegovy), a prescription-only weight-management medicine in Australia. Not an advertisement and not medical advice.

TreatCompare Editorial Team · Healthcare Price Research

Published 10 May 2026Updated 12 May 2026

Important information for Australian consumers. Semaglutide 2.4mg is a prescription-only (Schedule 4) medicine in Australia, supplied under the brand name Wegovy. Australian regulations restrict the advertising of prescription medicines to consumers, so this article is general patient information — it is not an advertisement, not an offer of sale, and not medical advice. Whether semaglutide 2.4mg is clinically appropriate for you is a decision for an AHPRA-registered prescriber following an assessment.

This article is a short patient-information landing. For the full patient information — TGA-approved indication, what to discuss with an AHPRA-registered prescriber, PBS context and the service-level cost components of a private consultation — see Semaglutide 2.4mg in Australia — Patient Information. For consumer information about Australian weight-management treatment more generally, see the weight-management hub.

What this article does not do

This article does not list semaglutide 2.4mg prices, compare it to other medicines on price, list provider pricing for it, or recommend a buying pathway. The medicine itself is priced by the dispensing pharmacy.

If you have spotted an error

Please tell us via the corrections route.

Important context

Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.

Source type: TreatCompare compiled research
Primary source: Provider-published information and TreatCompare research
Reporting period: 2026-05-12
Last updated: 2026-05-12
Figure type: Mixed sources
Use: Research and comparison only

Are you a clinic, provider or data owner?

If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.

Request a correction View methodology

Australia hub

Australia healthcare cost guides

View all Australia guides

Australia healthcare cost hub Weight loss injection prices Australia Mounjaro, Ozempic and Wegovy cost guide IVF cost and funding Australia Egg freezing cost Australia Private GP prices Australia Private blood test prices Australia Private dental prices Australia IVF cost Australia IVF clinics and costs by state Australian IVF clinic dataset Lower-cost IVF clinics Australia IVF medication costs Australia IVF clinics Melbourne and Victoria

Data funnel

Help improve Australian healthcare price data

TreatCompare gets more useful when readers send real quotes, providers verify listings, and outdated claims are corrected. Submissions are reviewed before publication.

I represent a provider

Update a listing, package fee, source URL, registration detail or location.

Update provider data ->

Something looks wrong

Flag an incorrect price, outdated source, missing inclusion or disputed claim.

Report a data issue ->

AU weight-management depth

Compliant Australian depth without prescription-medicine price advertising

Australian weight-management depth should focus on service fees, prescriber checks, PBS/Medicare context and pathway transparency rather than brand-name medicine price tables.

Search target	Price signal	Depth angle	Next data point
Weight-management service costs	Consultation, follow-up and service-fee components	No brand-name prescription medicine price comparison	Service fee, follow-up cadence and cancellation terms
Best online weight-loss programs	Program structure and inclusion checks	Prescriber registration, pharmacy pathway and support model	Provider service inclusions without medicine price inducement
Juniper vs Mosh	Service-route comparison only	Consultation model, clinician access and support terms	Non-POM service fee and support comparison
PBS and Medicare context	PBS eligibility and consultation rebate context	General consumer information with AHPRA verification	Current PBS status and prescriber-check steps

The AU weight-loss hub already avoids consumer-facing brand-name prescription medicine price tables.

Provider depth can still rank when framed around service routes, checks and inclusions.

AHPRA, PBS and TGA context should remain visible above any provider directory.

Frequently asked questions

What is semaglutide 2.4mg?

Semaglutide 2.4mg is a prescription-only (Schedule 4) medicine in Australia, supplied under the brand name Wegovy. It is TGA-approved for weight management in adults who meet the clinical criteria set out in its Australian Register of Therapeutic Goods entry. A separate semaglutide product (Ozempic) is TGA-approved for type 2 diabetes only.

Is semaglutide 2.4mg PBS-subsidised for weight management?

Semaglutide 2.4mg is not currently PBS-subsidised for weight management in Australia. The cost of the medicine is generally paid privately. PBS schedules change; check pbs.gov.au for current status.

Why does this page not list semaglutide 2.4mg prices?

Australian regulations restrict the advertising of prescription medicines to consumers. Pairing a brand name and price in a consumer context is treated as advertising under the TGA Therapeutic Goods Advertising Code, so TreatCompare does not display Australian prescription-medicine prices.